FMP
Currenc Group, Inc.
CURR
NASDAQ
Currenc Group, Inc. engages in operating a fintech banking platform. It operates through the following segments: Remittance Services, Sales of Airtime, and Other Services. The company is headquartered in Singapore.
1.61 USD
0.04 (2.48%)
Latest CURR News
Stuart Mooney
Mar 25, 2025
CURRENC Group Inc. (Nasdaq: CURR) Financial Challenges Despite Meeting Earnings Estimates
CURRENC Group Inc. (Nasdaq: CURR) is a fintech company specializing in AI solutions for financial institutions. On March 25, 2025, CURR reported its earnings, revealing an earnings per share (EPS) of -$0.05, which matched the estimated EPS of -$0.05. The company also reported actual revenue of $9.8 million, aligning perfectly with the estimated revenue of $9.8 million. Despite meeting earnings and revenue estimates, CURR faces financial challenges. The company has a negative price-to-earnings (...
Andrew Wynn
Mar 24, 2025
CURRENC Group Inc. (NASDAQ: CURR) Earnings Preview and Financial Health Analysis
CURRENC Group Inc. (NASDAQ: CURR) is a prominent player in the fintech industry, specializing in AI solutions for financial institutions. The company is set to release its quarterly earnings on March 25, 2025. Analysts predict an earnings per share (EPS) of -$0.05, with projected revenue of approximately $9.8 million. This release will provide insights into the company's financial health and future prospects. Despite a negative price-to-earnings (P/E) ratio of -24.65, CURR remains a key partici...
Andrew Wynn
Mar 18, 2025
CURRENC Group Inc. (CURR) Financial and Strategic Insights
CURRENC Group Inc., trading on Nasdaq under the symbol CURR, is a fintech company specializing in AI solutions for financial institutions. On March 18, 2025, CURR reported an earnings per share (EPS) of -$0.05, which matched the estimated EPS. The company's revenue for this period was $9.8 million, aligning perfectly with the estimated revenue. CURRENC has announced a collaboration with ARC Group to launch the CURR-ARC AI Fund 1, aiming to raise up to $100 million. This fund focuses on AI data ...
Accesswire
Apr 26, 2023
Avenir Wellness Solutions (OTCQB:CURR) to Present at the Planet MicroCap Showcase - Live Webcast Available
Presentation TODAY at 1:30PM Pacific Time (4:30 PM Eastern Time) SHERMAN OAKS, CA / ACCESSWIRE / April 26, 2023 / Avenir Wellness Solutions, Inc. ("Avenir Wellness") (OTCQB:CURR), a proprietary broad platform technology and wellness company, announced today that it will be presenting at the Planet MicroCap Showcase TODAY Wednesday, April 26, 2023, at 1:30 PM Pacific Time (4:30 PM Eastern Time). The Company's CEO, Nancy Duitch, will be presenting.
Newsfile Corp
Nov 10, 2022
Avenir Wellness Solutions to Present at Investor Summit Group's Q4 Conference
Sherman Oaks, California--(Newsfile Corp. - November 10, 2022) - Avenir Wellness Solutions, Inc. (f/k/a CURE Pharmaceutical Holding Corp.) (OTCQB: CURR) today announced that CEO Nancy Duitch will be attending the Q4 Investor Summit live in NYC at the Sheraton Times Square.
Newsfile Corp
Oct 24, 2022
Cure Pharmaceutical Holding to Present at the LD Micro Main Event XV
Presentation on Tuesday, October 25 at 12:30 PM Pacific Time (3:30 PM Eastern)Oxnard, California--(Newsfile Corp. - October 24, 2022) - Cure Pharmaceutical Holding Corp. (OTCQB: CURR) ("CURE"), a broad wellness platform technology company that develops proprietary wellness, nutraceutical, and topical delivery systems, announced today that it will be presenting at the 12th annual Invitational on Tuesday October 25 at 12:30 PM Pacific Time (3:30 PM Eastern) at the Luxe Sunset Boulevard Hotel. Nanc...
Benzinga
Aug 18, 2021
CURE Pharmaceutical Q2 2021 Revenue Spikes 700% After Increased Sales From Seba Labs Products Including A CVS Deal
Pharmaceutical company CURE Pharmaceutical Holding Corp. (OTC:CURR) announced earnings results on Tuesday for the quarter ended June 30, revealing revenue of $2.1 million. That's a year-over-year increase of 700%.
Business Wire
Jun 15, 2021
CURE Pharmaceutical to Present at H.C. Wainwright 2021 Psychedelics in Psychiatry and Beyond Virtual Conference
OXNARD, Calif.--(BUSINESS WIRE)--CURE Pharmaceutical Holding Corp. (OTC: CURR), a technology focused, vertically integrated drug delivery and product development company in the pharmaceutical and health & wellness markets, announced today that its Chief Business Officer Jonathan Berlent will participate in a virtual presentation at the H.C. Wainwright Psychedelics in Psychiatry and Beyond Virtual Conference on Thursday, June 17. "The potential therapeutic benefits of psychedelics to treat m
Benzinga
Jun 11, 2021
Federally Compliant Medical Cannabis In The US? One Company Is Doing It
CURE Pharmaceutical (OTC:CURR) has signed an agreement with Biopharmaceutical Research Company (BRC) to produce federally compliant medical cannabis, CBD and THC products. BRC will provide the cannabinoid ingredients and CURE will use them to begin the development of CBD and THC oral thin films for CURE's clinical studies targeted at advancing veteran health.
Business Wire
Jun 10, 2021
CURE Pharmaceutical Signs Agreement to Develop CBD and THC Oral Thin Films and Conduct Clinical Studies Targeting Veteran Health
OXNARD, Calif.--(BUSINESS WIRE)--CURE Pharmaceutical Holding Corp. (OTC: CURR), a vertically integrated drug delivery and product development company, announced today that it has signed a partnership agreement with Biopharmaceutical Research Company, (BRC), an active Drug Enforcement Administration (DEA) license holder, to produce federally-compliant cannabis-based medical products. Currently, CURE uses its Schedule 1 DEA license for the development of Cannabis (THC) oral film products and othe
